CSI Market
Sign In | Register

Mallinckrodt Plc (MNKKQ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MNKKQ Annual Cash Flow →
Tracking cash flow results across Mallinckrodt Plc to Nov 14 2023 helps illustrate how Sep 30 2026's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
9 Months 		(Jun 30 2026) (Jun 27 2025) (Dec 27 2024) (Nov 14 2023)
Operating Activities
Income-430.10
Depreciation & amortization172.70
Amortization of Other Assets155.10
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges201.70
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories6.90
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-150.30
Share-based Compensation45.30
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable95.10
Increase (Decrease) in Accounts Payable-8.20
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-75.30
Other Noncash Income (Expense)6.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities271.10
Discontinued operations0.00
Net Cash flow from Operating Activities290.00
Investing Activities
Capital Expenditures-21.40
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested20.40
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.60
Other Net10.20
Discontinued operations0.00
Net Cash Flow from Investing Activities9.80
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-11.30
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-3.40
Other net-9.70
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-24.40
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow268.60
Total Cash Flow273.90
4 historic quarters locked

Sign in to unlock the full Mallinckrodt Plc cash flow history.

Sign In Create Free Account

About Keenova Therapeutics Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 10, 2026
  • Source: mnk-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-072839

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI